share_log

艾美疫苗:(經修訂) 截至二零二三年十一月三十日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

香港交易所 ·  Apr 3 04:31
Summary by Moomoo AI
艾美疫苗股份有限公司於2024年4月3日重新提交了截至2023年11月30日的證券變動月報表。報告顯示,公司的H股和內資股在過去一個月的法定/註冊股本及已發行股份均無變動,H股結存為492,173,711股,內資股結存為718,888,888股。此外,公司首次公開發售前的僱員股份激勵計劃下,本月底結存的股份期權數目為10,920,000,較上月減少350,000。艾美疫苗確認所有相關上市及法律條件已遵守,並無其他股份變動。
艾美疫苗股份有限公司於2024年4月3日重新提交了截至2023年11月30日的證券變動月報表。報告顯示,公司的H股和內資股在過去一個月的法定/註冊股本及已發行股份均無變動,H股結存為492,173,711股,內資股結存為718,888,888股。此外,公司首次公開發售前的僱員股份激勵計劃下,本月底結存的股份期權數目為10,920,000,較上月減少350,000。艾美疫苗確認所有相關上市及法律條件已遵守,並無其他股份變動。
EMERY VACCINES CO., LTD. REFILED ON APRIL 3, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED NOVEMBER 30, 2023. THE REPORT SHOWS THAT THE COMPANY'S H SHARES AND INWARD EQUITY WERE UNCHANGED IN THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OVER THE PAST MONTH, WITH 492,173,711 SHARES DEPOSITED AND 718,888,888 SHARES DEPOSITED IN THE INTERNAL SHARES. In addition, under the Company's Employee Stock Incentive Program prior to its initial public offering, the number of stock options outstanding at the end of this month was 10,920,000, down 350,000 from the previous month. AMIE CONFIRMS THAT ALL RELEVANT LISTING AND LEGAL CONDITIONS HAVE BEEN COMPLIED WITH AND THAT NO OTHER SHARE CHANGES HAVE BEEN MADE.
EMERY VACCINES CO., LTD. REFILED ON APRIL 3, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED NOVEMBER 30, 2023. THE REPORT SHOWS THAT THE COMPANY'S H SHARES AND INWARD EQUITY WERE UNCHANGED IN THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES OVER THE PAST MONTH, WITH 492,173,711 SHARES DEPOSITED AND 718,888,888 SHARES DEPOSITED IN THE INTERNAL SHARES. In addition, under the Company's Employee Stock Incentive Program prior to its initial public offering, the number of stock options outstanding at the end of this month was 10,920,000, down 350,000 from the previous month. AMIE CONFIRMS THAT ALL RELEVANT LISTING AND LEGAL CONDITIONS HAVE BEEN COMPLIED WITH AND THAT NO OTHER SHARE CHANGES HAVE BEEN MADE.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more